Recombinant CD25 抗体
Quick Overview for Recombinant CD25 抗体 (ABIN7543079)
抗原
See all CD25 (IL2RA) 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- Anti-CD25 [7G7/B6], Rabbit IgG, kappa
-
特异性
- This antibody is specific for human interleukin 2 (IL2) receptor alpha (IL2RA), which is expressed by activated T cells. IL2R alpha chains can exist as low-affinity monomers, or can non-covalently associate with IL2R beta chains to form high-affinity dimers.
-
产品特性
-
Original Species of Ab: Mouse
Original Format of Ab: IgG2a
-
纯化方法
- Protein A affinity purified
-
免疫原
- This antibody was raised by injecting mice intraperitoneally and subcutaneously with Hong Kong influenza virus-stimulated PBMC, which express human IL-2 receptor alpha. Immune splenocytes were subsequently fused with SP2/0 cells to produce stable hybridomas.
-
亚型
- IgG kappa
-
-
-
-
应用备注
- This antibody recognises human IL2RA, as confirmed by immunofluorescence, FACS and immunoprecipitation analysis (Rubin et al, 1985). Sequential immunoprecipitations have shown that 7G7/B6 binds to the same 50-55 kD surface molecule as anti-Tac, a murine mAb specific for the human IL-2 receptor. However, 7G7/B6 does not compete with IL-2 and anti-Tac for binding to IL2R expressed by activated PBMCs, indicating that 7G7/B6 recognises a distinct epitope on IL2R. 7G7/B6, therefore, recognises a different epitope on IL-2Rα to the humanised anti-Tac monoclonal antibody daclizumab (Zhang et al, 2006). Equally, although 7G7/B6 binds to a different epitope on IL2 Rα to IL-2, and is, therefore, unable to block IL-2/IL2 Rα interaction, 7G7/B6 is still able to delay tumour progression and prolong survival in mouse models of adult T-cell leukaemia (ATL) (Phillips et al, 2000), likely by FcR-mediated death by FcRIII-expressing cells. Administration of 7B7/B6 radiolabelled with astatine-211 (211At-7G7/B6) to karpas299 leukaemia-bearing mice significantly increased survival, highlighting the potential therapeutic role for 211At-7G7/B6 in the treatment of patients with CD25-expressing leukaemias (Zhang et al, 2006). Indeed, 211At-7G7/B6 in combination with daclizumab induces significant long-term survival in murine models of adult T-cell leukaemia (Zhang et al, 2006). Additionally, 7G7/B6 armed with Yttrium-90 (90Y) significantly extends the survival of SUDHL-1 lymphoma-bearing mice significantly (Zhang et al, 2009), and presents another option for combination therapy with daclizumab. 7G7/B6 has been used in flow cytometric measurements of energy transfer efficiencies between FITC- and Cy3-conjugated mAbs bound to IL-2Rα, β, and γ subunits on Kit 225 K6 T cells, revealing that IL-2R subunits are preassembled on resting cells (Damjanovich et al, 1997). This antibody has also been used in an ELISA to assess serum levels of IL-2R (Uziel et al, 1994).
-
说明
-
This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- PBS with 0.02 % Proclin 300.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- CD25 (IL2RA) (Interleukin 2 Receptor, alpha (IL2RA))
-
别名
- CD25
-
背景
- IL2-RA, Interleukin-2 receptor subunit alpha, IL-2-RA, IL-2R subunit alpha, TAC antigen, p55, Receptor for interleukin-2
-
UniProt
- P01589
-
途径
- JAK/STAT Signaling, Growth Factor Binding, Activated T Cell Proliferation
抗原
-